The opening visit for the DRL-IND-NDA08-TEG/2022 project

The opening of the center was held: patients with erosive GERD will participate in an international, multicenter, prospective, randomized, double–blind, actively controlled, parallel-group study to evaluate the efficacy and safety of tegoprazane, sponsored by Dr. Reddy's Laboratories Ltd, India.

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen